EP Patent
EP1663968A1 — Process for the preparation of pure levetiracetam
Assigned to Ranbaxy Laboratories Ltd · Expires 2006-06-07 · 20y expired
What this patent protects
The invention relates to processes for the preparation of pure levetiracetam. The invention also relates to pharmaceutical compositions that include the pure levetiracetam.
USPTO Abstract
The invention relates to processes for the preparation of pure levetiracetam. The invention also relates to pharmaceutical compositions that include the pure levetiracetam.
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.